Literature DB >> 22507813

Thrombosis in myeloproliferative and myelodysplastic syndromes.

Raffaele Landolfi1, Leonardo Di Gennaro.   

Abstract

Myeloproliferative neoplasms (MPNs) and myelodisplastic syndromes (MDs) are clonal disorders caused by mutations of myeloid stem cells. Among MPNs, polycythemia vera and essential thrombocythemia are relatively benign disorders in which arterial and venous thromboses represent the main cause of morbidity and mortality. The natural history of MDs is often complicated by both thromboses and haemorrhages, mainly due to platelet quantitative and quantitative anomalies, as well as to treatment complications. In this short review, we focus the attention on the main aspects of thrombophilia in both disorders.

Entities:  

Mesh:

Year:  2012        PMID: 22507813     DOI: 10.1179/102453312X13336169156898

Source DB:  PubMed          Journal:  Hematology        ISSN: 1024-5332            Impact factor:   2.269


  5 in total

1.  Superior mesenteric vein thrombosis as an early presentation of myelodysplastic syndrome: a case report.

Authors:  Min Jung Kim; Hyun Joo Song; Woo Kun Kim; Sun Hyung Kim
Journal:  Intest Res       Date:  2014-04-29

2.  Risks of bleeding and thrombosis in intensive care unit patients with haematological malignancies.

Authors:  Lene Russell; Lars Broksø Holst; Lars Kjeldsen; Jakob Stensballe; Anders Perner
Journal:  Ann Intensive Care       Date:  2017-12-11       Impact factor: 6.925

3.  Renal biopsy cases in myeloproliferative neoplasms (MPN).

Authors:  Kumi Fujita; Kazuhiro Hatta
Journal:  CEN Case Rep       Date:  2013-03-12

4.  Erythropoiesis-stimulating agents and cardiovascular events in patients with myelodysplastic syndrome and multiple myeloma.

Authors:  Erzsébet Horváth-Puhó; Marit M Suttorp; Henrik Frederiksen; Tiny Hoekstra; Olaf M Dekkers; Lars Pedersen; Suzanne C Cannegieter; Friedo W Dekker; Henrik Toft Sørensen
Journal:  Clin Epidemiol       Date:  2018-09-28       Impact factor: 4.790

Review 5.  Hematological Malignancies and Arterial Thromboembolism.

Authors:  Nathan Visweshwar; Michael Jaglal; Lubomir Sokol; Benjamin Djulbegovic
Journal:  Indian J Hematol Blood Transfus       Date:  2019-01-28       Impact factor: 0.900

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.